Three companies are combining to form a value-based kidney care company said to be worth $2.4 billion, Home Health Care News reports. Fresenius Health Partners, InterWell Health and Cricket Health will join powers underneath the InterWell Health brand.
The news is another example of the rapidly budding kidney care market. Even more so, it’s an example of the innovations taking place in the market, with in-home care solutions being one of them.
With a total addressable market of $170 billion, more than $6 billion of medical costs under management, and over 100,000 covered lives, the new company will accelerate growth in the mid- and late-stage chronic kidney disease value-based care population and will build upon a strong foundation of success to accelerate the transformation of kidney care. By 2025, the company expects to engage and manage the care of more than 270,000 Americans living with kidney disease, increasing its medical costs under management to $11 billion.
The new InterWell Health will be separated from Fresenius Medical Care, with the benefit of the company’s experience, expertise, resources, and services. With the financial and strategic support of leading investors, including Valtruis, a WCAS company; Oak HC / FT; Swan Ventures; and Blue Shield of California, the new company will have the financial flexibility to make further investments to strategically grow and explore adjacent value-based care opportunities. Read more.
